Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001415889-25-008417

CHIEF EXECUTIVE OFFICER acquired 42,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lettmann Jason CHIEF EXECUTIVE OFFICER 2025-03-14 Grant or award +42,000 212,270 D
Loading xslF345X05/form4-03182025_080326.xml…